IP Library › Granted Patent US 7,247,614
Granted Patent B2
US 7,247,614 · App. 11/047,327 · Granted Jul 24, 2007

Composition and method for modulating somatolactogenic function

Assignee: Trustees of the University of Pennsylvania
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,247,614
App. No.
11/047,327
Granted
Jul 24, 2007
Kind
B2
Abstract

A human prolactin-binding protein and compositions and methods using this protein are provided.

Claims (2)

1. A method of inhibiting Nb2 cells comprising contacting Nb2 cells with a prolactin-binding protein, wherein said prolactin-binding protein is produced recombinantly and consists of SEQ ID NO: 3.

2. A method of inhibiting Nb2 cells comprising contacting Nb2 cells with a composition consisting of a recombinantly produced prolactin-binding protein of SEQ ID NO: 3 and a pharmaceutically acceptable vehicle.

Assignments (1)
CONFIRMATORY LICENSE Recorded Nov 27, 2022
From: UNIVERSITY OF PENNSYLVANIA
To: NIH - DEITR
Reel/Frame 061884/0011 →
Continuity (3)
Continuation 1002907900 · Dec 21, 2001
Provisional Application 6025828500 · Dec 22, 2000
Related Publication 20050164309A1 · Jul 28, 2005